Activation of Adenosine A2A Receptor Attenuates Inflammatory Response in a Rat Model of Small-for-Size Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 5, 2010, Pages 1915-1920

  Tang, L M ^a   Zhu, J F ^a   Wang, F ^a   Qian, J ^a   Zhu, J ^a   Mo, Q ^a   Lu, H H ^a   Li, G Q ^a   Wang, X H ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIVER GRAFT; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ALANINE TRANSAMINASE; ANIMALS; CHEMOKINE CXCL2; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER TRANSPLANTATION; MALE; NF-KAPPA B; ORGAN SIZE; PEROXIDASE; PHENETHYLAMINES; PHOSPHORYLATION; RATS; RATS, INBRED LEW; RECEPTOR, ADENOSINE A2A; TRIAZINES; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953661583     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.084     Document Type: Article

References (24)

1. Ikegami T., Shimada M., Imura S., et al. Current concept of small-for-size grafts in living donor liver transplantation. Surg Today 38 (2008) 971
2. Song J., Zhang Y.W., Yao A.H., et al. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transpl Int 21 (2008) 372
3. Yao A., Li X., Pu L., et al. Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation. Transpl Immunol 18 (2007) 37
4. Perkins J.D. Treatment of small-for-size syndrome. Liver Transpl 14 (2008) 571
5. Lentsch A.B., Kato A., Yoshidome H., et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32 (2000) 169
6. Tang L.M., Wang Y.P., Wang K., et al. Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation. Transpl Int 20 (2007) 93
7. Lampiasi N., Azzolina A., D'Alessandro N., et al. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-(kappa)B inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol Pharmacol 76 (2009) 290
8. Verstrepen L., Carpentier I., Verhelst K., et al. A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochem Pharmacol 78 (2009) 105
9. Qian J.M., Zhang H., Wu X.F., et al. Improvement of recipient survival after small size graft liver transplantation in rats with preischemic manipulation or administering antisense against nuclear factor-kappaB. Transpl Int 20 (2007) 784
10. Takahashi Y., Ganster R.W., Gambotto A., et al. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 283 (2002) G1175
11. Fabrega E., Orive A., Garcia-Unzueta M., et al. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. Clin Transplant 20 (2006) 383
12. Armstrong D.A., Major J.A., Chudyk A., et al. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 75 (2004) 641
13. Matsutani T., Kang S.C., Miyashita M., et al. Liver cytokine production and ICAM-1 expression following bone fracture, tissue trauma, and hemorrhage in middle-aged mice. Am J Physiol Gastrointest Liver Physiol 292 (2007) G268
14. Hung C.F., Huang T.F., Chen B.H., et al. Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Eur J Pharmacol 586 (2008) 275
15. Ben-Ari Z., Pappo O., Sulkes J., et al. Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver. Apoptosis 10 (2005) 955
16. Sitkovsky M.V., Lukashev D., Apasov S., et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22 (2004) 657
17. Lappas C.M., Sullivan G.W., and Linden J. Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Invest Drugs 14 (2005) 797
18. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916
19. Fredholm B.B., Ijzerman A.P., Jacobson K.A., et al. International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol Rev 53 (2001) 527
20. Day Y.-J., Li Y., Rieger J.M., et al. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol 174 (2005) 5040
21. Sevigny C.P., Li L., Awad A.S., et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 178 (2007) 4240
22. Zarek P.E., Huang C.-T., Lutz E.R., et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111 (2008) 251
23. Garcia G.E., Truong L.D., Li P., et al. Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. FASEB J 22 (2008) 445
24. Hasko G., and Pacher P. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 83 (2008) 447